FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAgilent Technologies, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
A
Agilent Technologies, Inc. Stock AnalysisComprehensive stock analysis for Agilent Technologies, Inc. (A) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisA
A
Agilent Technologies, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
A
  1. Home
  2. Stocks
  3. Agilent Technologies, Inc.

Agilent Technologies, Inc.

🇺🇸A•NYSE

Agilent Technologies, Inc.

🇺🇸A•NYSE
Market cap
$48.76B
Sentiment

Your view on A

Mkt Cap
$48.76B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Agilent Technologies, Inc.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Padraig McDonnell
Headquarters
5301 Stevens Creek Boulevard, Santa Clara, CA, US
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Padraig McDonnell
Headquarters
5301 Stevens Creek Boulevard, Santa Clara, CA, US
Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.

It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics.

The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services.

The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Agilent Technologies, Inc. from FRC's valuation model, read against the market price. A last traded at $172.92, 34.0× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Agilent Technologies, Inc.. Starting points for Agilent Technologies, Inc.: P/E 34.0, EPS $5.11, beta 1.24 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Agilent Technologies, Inc.. Agilent Technologies, Inc. paid $1.02 per share over the last year — a 0.6% yield at the current $172.92 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Agilent Technologies, Inc.. Trailing twelve-month EPS for Agilent Technologies, Inc. stands at $5.11. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$172.67

average of 15 firms, last 12 months

 

$172.67

Low $150.00

Median $175.00

High $195.00

 

Analyst Ratings

Buy17 firms, last 12 months
  • Strong Buy0
  • Buy15
  • Hold2
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrOct 2026Next QtrJan 2027Current YearFY Oct 2026Next YearFY Oct 2027
Avg. estimate$1.73$1.50$6.20$6.70
Low estimate$1.72$1.47$6.19$6.52
High estimate$1.74$1.52$6.42$6.98
No. of analysts1271313
Year-ago EPS$1.59$1.36$4.57—
Growth+8.6%+10.0%+35.7%—

Revenue Estimate

RevenueCurrent QtrOct 2026Next QtrJan 2027Current YearFY Oct 2026Next YearFY Oct 2027
Avg. estimate$1.99B$1.92B$7.50B$7.99B
Low estimate$1.97B$1.91B$7.49B$7.93B
High estimate$2.00B$1.94B$7.71B$8.03B
No. of analysts1161516
Year-ago revenue$1.86B$1.80B$6.95B—
Growth+6.9%+7.1%+7.9%—
Recent analyst actions15 rating and price-target changes, latest Oct 26, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Agilent Technologies, Inc.. Agilent Technologies, Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold A20 companies · 8 funds
Compare A with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • BIOBio-Rad Laboratories, Inc.Medical - Devices$9.7B
  • BRKRBruker CorporationMedical - Devices$9.3B
  • DHRDanaher CorporationMedical - Diagnostics & Research$161.9B
  • MTDMettler-Toledo International Inc.Medical - Diagnostics & Research$34.4B
  • QGENQiagen N.V.Medical - Diagnostics & Research$10.3B
  • RVTYRevvity, Inc.Medical - Diagnostics & Research$16.6B
  • SHMZFShimadzu CorporationHardware, Equipment & Parts$8.1B
  • SSMXYSysmex CorporationMedical - Specialties$5.5B

More Medical - Diagnostics & Research companies

  • ADVBAdvanced Biomed Inc. Common StockNASDAQ$4M
  • ANPCFCellbxhealth PLCOTC$4M
  • ARYCArrayit CorporationOTC$79,348
  • AVCR.VAvricore Health Inc.TSXV$3M
  • AVCRFAvricore Health Inc.OTC$6M
  • BDSXBiodesix, Inc.NASDAQ$73M
  • BDX.AXBCAL Diagnostics LimitedASX
  • BIAFbioAffinity Technologies, Inc.NASDAQ$13M
  • BIAFWbioAffinity Technologies, Inc.NASDAQ$5M
  • BIOCQBiocept, Inc.OTC$263
  • BIOQBioqual, Inc.OTC$34M
  • BLLNBillionToOne, Inc.NASDAQ$4.6B

ETFs holding Agilent Technologies, Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.08%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.07%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.47%
  • IVViShares Core SP 500 ETF$852.9B in assets0.08%
  • HHL.TOHarvest Healthcare Leaders Income ETF$2.2B in assets4.65%
  • FIWFirst Trust Water ETF$1.9B in assets4.25%
  • PHOInvesco Water Resources ETF$2.1B in assets4.22%
  • KATScharf ETF$676M in assets3.25%

Largest holders first, then the funds most concentrated in A.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Agilent Technologies, Inc., and how their positions are changing. At a $48.76B market value, institutional positions materially move Agilent Technologies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Agilent Technologies, Inc. executives and directors. Shares of Agilent Technologies, Inc. have traded between $96.43 and $153.84 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Agilent Technologies, Inc.. Agilent Technologies, Inc. is a $48.76B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Agilent Technologies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Agilent Technologies, Inc.. Coverage tracks Agilent Technologies, Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Agilent Technologies, Inc.

A Analysis
Fair
Past4
Growth2
Health3
Profit3
Value1

News

Latest Market News